Le Lézard
Classified in: Health, Business
Subject: LIC

G-CON Manufacturing and Vanrx Pharmasystems Announce the Launch of Microcell POD


COLLEGE STATION, Texas, Jan. 20, 2020 /PRNewswire-PRWeb/ -- G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, and Vanrx Pharmasystems, known for its advanced aseptic filling machines, today announced the companies are working together to offer the Microcell POD, the first and only turnkey facility for aseptic filling of advanced therapies.

The Microcell POD is comprised of Vanrx's Microcell Vial Filler installed inside G-CON's award-winning prefabricated cleanroom POD. It is the only fully integrated, pre-qualified, pre-installed aseptic filling facility with the ability to be shipped globally. The new product supports both organizations' missions of providing solutions that bring products to market faster. The Microcell POD requires a lead time of only 3 months.

"Companies making targeted drug products including gene therapies, mRNA, and personalized cancer vaccines have to a lot of problems to solve in bringing these new modalities to market. It makes sense to combine the Microcell with the G-CON's POD products because it provides certainty of performance and speed to market, while automating the crucial step of aseptic processing within an agile, completely closed system," said Chris Procyshyn, CEO and co-founder of Vanrx.

"Advanced therapies are rapidly entering a maturity stage in which clinical material or commercial manufacturing capacity are needed. Companies want to fast track with reliable budgets and delivery times, and avoid long, expensive design phases. Our new POD product is standardized and fully designed to fulfill the delivery time need. Moreover, filling capacity is and has been a major bottleneck, so G-CON joined forces with the Vanrx team to create a fully functional, prequalified filling package for our customers." Maik Jornitz stated. "We are very happy to have the ability to supply a key critical manufacturing step as a drop-ship product to the industry."
The Microcell POD is ideal for drug development, and the manufacturing of personalized medicines and clinical trial supplies.

G-CON and Vanrx are exhibiting at Phacilitate Miami, January 21?24, 2020 with an in-booth presentation leading up to the "G-CON / Vanrx East Coast Roadshow Tour" in April. To learn more about the Microcell POD, register to attend our upcoming product launch events:

About G-CON Manufacturing
G-CON Manufacturing designs, builds and installs prefabricated cleanrooms. G-CON's POD portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD cleanrooms surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing once the production process reaches its lifecycle end. For more information, please visit G-CON's website at https://www.gconbio.com.

About Vanrx Pharmasystems
Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use robotics, machine vision and gloveless isolator technologies to automate the packaging of injectable drugs into vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies.

 

SOURCE G-CON Manufacturing, Inc.


These press releases may also interest you

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....

at 05:45
The Gross Law Firm issues the following notice to shareholders of InMode Ltd. . Shareholders who purchased shares of INMD during the...

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...



News published on and distributed by: